Adani Group has signed four Memorandums of Understanding (MoUs) with the Telangana government for an investment of over Rs 12,400 crore at ...

If one looks at any place in the world where there is significant fundamental drug research happening from multinational firms, there is re...

Asserting that it's a really exciting moment to be in the world of medicine and R&D, Narasimhan said: "RNA therapeutics are opening up a wh...

Sandeep Kataria, 49, who is currently Bata India’s CEO, has been elevated as global CEO of the company, as the current incumbent, Alexis Na...

In the absence of sustained investments by government, the cure for epidemics such as Covid-19 becomes a challenge, Novartis global CEO Vas...

Novartis is one of the oldest pharma MNCs known for anti-cancer and anti-diabetic drugs. Despite the patent expiry for its popular anti-dia...

Harvard geneticist David Reich breaks down the findings of two recent papers on the genetics of ancient Indians.

For the first time, we have a genetic model that fits statistically for most present-day South Asians: mixture of IVC-like people, and othe...

The findings are based on the study of the ancient genome in the skeletons excavated from Rakhigarhi.

Our chief focus for future investments will be: One on increasing our R&D footprint here over time. Second is data and digital.

At the peak of the digital boom in 2015, ventures like Flipkart, Zomato and Snapdeal reportedly hired over 30 CXO-level executives from Sil...

Jimenez is handing over the reins at a crucial juncture, with the drugmaker yet to make a decision on the future of its ailing Alcon eye-ca...